vs
Side-by-side financial comparison of ConnectOne Bancorp, Inc. (CNOB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
ConnectOne Bancorp, Inc. is the larger business by last-quarter revenue ($115.6M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). Over the past eight quarters, ConnectOne Bancorp, Inc.'s revenue compounded faster (32.5% CAGR vs 31.3%).
Citizens Republic Bancorp was a bank holding company for Citizens Bank, headquartered in Flint, Michigan. It merged with FirstMerit Bank in June 2013. It operated 219 branches and 248 ATMs in Michigan, Wisconsin, and Ohio. FirstMerit merged with Huntington Bancshares in 2016.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CNOB vs PBYI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $115.6M | $75.5M |
| Net Profit | $37.8M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | 32.7% | — |
| Revenue YoY | — | 27.7% |
| Net Profit YoY | 86.8% | — |
| EPS (diluted) | $0.72 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $115.6M | — | ||
| Q4 25 | $112.6M | $75.5M | ||
| Q3 25 | $121.4M | $54.5M | ||
| Q2 25 | $84.1M | $52.4M | ||
| Q1 25 | $70.2M | $46.0M | ||
| Q4 24 | $68.5M | $59.1M | ||
| Q3 24 | $65.6M | $80.5M | ||
| Q2 24 | $65.8M | $47.1M |
| Q1 26 | $37.8M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $41.0M | $8.8M | ||
| Q2 25 | $-20.3M | $5.9M | ||
| Q1 25 | $20.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $17.2M | $20.3M | ||
| Q2 24 | $19.1M | $-4.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | 22.7% | ||
| Q3 25 | 47.2% | 17.6% | ||
| Q2 25 | -30.1% | 12.7% | ||
| Q1 25 | 39.0% | 8.7% | ||
| Q4 24 | 38.6% | 22.6% | ||
| Q3 24 | 35.3% | 27.4% | ||
| Q2 24 | 39.1% | -4.6% |
| Q1 26 | 32.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 33.7% | 16.2% | ||
| Q2 25 | -24.1% | 11.2% | ||
| Q1 25 | 28.8% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 26.2% | 25.2% | ||
| Q2 24 | 28.9% | -9.6% |
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.88 | $0.26 | ||
| Q3 25 | $0.78 | $0.17 | ||
| Q2 25 | $-0.52 | $0.12 | ||
| Q1 25 | $0.49 | $0.06 | ||
| Q4 24 | $0.48 | $0.40 | ||
| Q3 24 | $0.41 | $0.41 | ||
| Q2 24 | $0.46 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $344.5M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $1.6B | $130.3M |
| Total Assets | $14.2B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $344.5M | — | ||
| Q4 25 | $380.9M | $97.5M | ||
| Q3 25 | $542.7M | $94.4M | ||
| Q2 25 | $596.5M | $96.0M | ||
| Q1 25 | $292.6M | $93.2M | ||
| Q4 24 | $356.5M | $101.0M | ||
| Q3 24 | $247.2M | $96.7M | ||
| Q2 24 | $293.5M | $96.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $130.3M | ||
| Q3 25 | $1.5B | $115.3M | ||
| Q2 25 | $1.5B | $104.7M | ||
| Q1 25 | $1.3B | $97.1M | ||
| Q4 24 | $1.2B | $92.1M | ||
| Q3 24 | $1.2B | $71.1M | ||
| Q2 24 | $1.2B | $48.5M |
| Q1 26 | $14.2B | — | ||
| Q4 25 | $14.0B | $216.3M | ||
| Q3 25 | $14.0B | $202.9M | ||
| Q2 25 | $13.9B | $194.9M | ||
| Q1 25 | $9.8B | $196.2M | ||
| Q4 24 | $9.9B | $213.3M | ||
| Q3 24 | $9.6B | $220.7M | ||
| Q2 24 | $9.7B | $205.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $106.4M | $14.4M | ||
| Q3 25 | $37.4M | $9.7M | ||
| Q2 25 | $6.5M | $14.1M | ||
| Q1 25 | $14.9M | $3.6M | ||
| Q4 24 | $60.7M | $15.6M | ||
| Q3 24 | $-14.4M | $11.0M | ||
| Q2 24 | $22.3M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | $101.0M | $14.4M | ||
| Q3 25 | $33.9M | $9.7M | ||
| Q2 25 | $6.4M | $14.1M | ||
| Q1 25 | $14.6M | $3.6M | ||
| Q4 24 | $56.9M | $15.6M | ||
| Q3 24 | $-15.6M | $11.0M | ||
| Q2 24 | $22.2M | $1.0M |
| Q1 26 | — | — | ||
| Q4 25 | 89.7% | 19.1% | ||
| Q3 25 | 27.9% | 17.7% | ||
| Q2 25 | 7.6% | 26.8% | ||
| Q1 25 | 20.8% | 7.7% | ||
| Q4 24 | 83.1% | 26.4% | ||
| Q3 24 | -23.8% | 13.7% | ||
| Q2 24 | 33.7% | 2.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 2.8% | 0.0% | ||
| Q2 25 | 0.1% | 0.0% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 5.5% | 0.0% | ||
| Q3 24 | 1.9% | 0.0% | ||
| Q2 24 | 0.2% | 0.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.91× | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | 0.74× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.84× | 0.54× | ||
| Q2 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNOB
| Net Interest Income | $108.8M | 94% |
| Noninterest Income | $6.8M | 6% |
PBYI
Segment breakdown not available.
